Loading...
Printed on 6/29/2026
For informational purposes only. This is not medical advice.
The ABCDE criteria are the most widely recognized melanoma warning signs for skin self-examination. A = Asymmetry (one half doesn't match the other), B = Border irregularity (edges are ragged, notched, or blurred), C = Color variation (uneven distribution of color including brown, black, red, white, or blue), D = Diameter greater than 6mm (about pencil eraser size), E = Evolving (changing in size, shape, or color). While no single criterion is diagnostic, the presence of multiple ABCDE features increases concern for melanoma and warrants dermatology referral for dermoscopy and possible biopsy. Early detection is critical — 5-year survival for stage I melanoma is >95%. For melanoma patients undergoing chemotherapy, assess performance status with [ECOG Performance Status](/tools/ecog-performance) and calculate chemotherapy doses using [BSA Calculator](/tools/bsa-calculator). Monitor renal function with [eGFR Calculator](/tools/egfr-calculator). Assess skin disease quality of life with [DLQI Score](/tools/dlqi).
Formula: Count of 5 criteria present: Asymmetry, Border, Color, Diameter >6mm, Evolving.
Save your results with a free account
Keep a history of calculations, favorite tools, and access your dashboard anytime.
Assess the lesion in good natural lighting for Asymmetry (one half unlike the other), Border irregularity (ragged/notched edges), Color variation (multiple shades including black, blue, white, or red), Diameter greater than 6mm, and Evolving (any recent change in size, shape, or color).
Record which criteria are present. Evolution is the single most clinically important criterion because it indicates active change — melanomas typically grow and change over weeks to months. Any mole that is different from last month warrants evaluation regardless of other features.
Zero criteria: reassuring but not definitive — continue monthly self-exams. One criterion: monitor closely, consider dermatology referral (especially if E is positive). Two or more criteria: prompt dermatology referral for dermoscopy and possible biopsy. Any rapidly changing or bleeding lesion warrants urgent referral.
General public, high-risk individuals
The American Academy of Dermatology recommends monthly full-body skin self-exams. ABCDE provides a simple, memorable framework for evaluating moles. Higher-risk individuals (fair skin, family history, >50 moles, prior melanoma) should use this checklist regularly.
Primary care physicians, nurse practitioners
ABCDE provides a structured framework for opportunistic skin screening during routine visits. Any lesion meeting criteria warrants dermatology referral with documentation of the specific ABCDE findings present. Dermoscopy-equipped GPs achieve significantly higher sensitivity.
Dermatologists, dermatology nurses
ABCDE criteria guide initial naked-eye triage before dermoscopy. Documenting positive criteria in referral letters helps dermatologists prioritize urgency. Lesions meeting multiple criteria receive faster appointments than single-criterion referrals.
Telehealth providers, digital health platforms
ABCDE criteria are the basis for many AI-powered skin lesion apps. When evaluating teledermatology photos, clinicians use ABCDE as the initial scoring framework before recommending in-person dermoscopy or biopsy.
Dermatology nurses, public health workers
ABCDE is the foundation of national skin cancer awareness campaigns (Skin Cancer Foundation, Cancer Research UK). Melanoma Awareness Month (May) specifically promotes ABCDE education. Early-stage melanoma (Stage I) has >95% 5-year survival — detection makes the difference.
Medical students, primary care residents
ABCDE is a core learning objective for all clinicians who perform physical examinations. The mnemonic is designed for reliable recall in any clinical setting without reference materials, making it particularly valuable for non-specialist providers.
A mole that changes — grows larger, changes color, changes shape, or starts bleeding — is the most reliable warning sign of melanoma, even if all other ABCDE criteria appear normal. Ask patients: 'Has this mole changed in the past 6 months?' If yes, refer regardless of other features.
Most of a person's moles look similar to each other. A mole that stands out as distinctly different from the rest of the person's moles — the 'ugly duckling' — is suspicious regardless of ABCDE criteria. This complementary approach catches many melanomas missed by ABCDE alone.
Nodular melanoma (15% of melanomas) is often symmetric, uniformly colored, and smaller than 6mm early in its rapid growth phase. Amelanotic melanoma lacks pigment and appears pink. For elevated, firm, growing lesions, use the EFG criteria (Elevated, Firm, Growing rapidly) as a complement.
The American Cancer Society and AAD recommend annual professional skin exams for adults with fair skin, family history of melanoma, personal history of skin cancer, significant cumulative sun exposure, or more than 50 moles. Self-exams should be done monthly for high-risk individuals.
Take reference photos of all suspicious moles in natural light, held at a consistent distance. Compare monthly. Any mole that grows larger, darkens, or changes in any way between photos meets the E criterion and should be evaluated by a dermatologist.
Dermoscopy (dermatoscopy) increases melanoma detection sensitivity from about 65–70% with naked eye to 85–90% in trained hands. Patients with multiple suspicious moles or high melanoma risk should see a dermatologist with dermoscopy access, not rely on naked-eye ABCDE alone.
For clinicians trained in dermoscopy: blue-white veil, atypical pigment network, regression structures, and irregular dots/globules are the dermoscopic criteria most predictive of melanoma, augmenting naked-eye ABCDE assessment.
The ABCDE criteria were developed by Friedman, Rigel, and Kopf (1985) at NYU and have been the standard for melanoma self-examination for 40 years. Stage I melanoma (localized, <1mm Breslow thickness) has a 5-year survival exceeding 95% (SEER data). The American Academy of Dermatology recommends annual professional skin exams for high-risk individuals.
Your result indicates how many of the five ABCDE melanoma warning criteria are present in the mole being evaluated. Having zero criteria is reassuring but does not completely exclude melanoma. One criterion present warrants monitoring and consideration of dermatology referral, particularly if the criterion is Evolution (change over time). Two or more criteria present significantly increases concern for melanoma and warrants prompt dermatology referral for dermoscopy and possible biopsy.
No set number of ABCDE criteria is diagnostic of melanoma — the checklist is a screening tool to help identify suspicious lesions. Some melanomas (particularly amelanotic or nodular melanomas) may not meet any ABCDE criteria. Conversely, some benign lesions (such as seborrheic keratoses or dysplastic nevi) may meet multiple criteria. A biopsy is the only way to definitively diagnose melanoma.
Use this checklist for skin self-examination of moles and pigmented lesions. The American Academy of Dermatology recommends regular self-examination of the skin for new or changing moles. It is particularly useful when a patient or family member notices a mole that looks different from others (the ugly duckling sign) or when a mole appears to be changing.
Clinicians can use this as a quick screening framework during skin examinations, though dermoscopy provides far greater diagnostic accuracy than naked-eye ABCDE assessment alone. Any lesion meeting ABCDE criteria should be evaluated by a dermatologist with dermoscopy expertise.
The ABCDE criteria were designed primarily for superficial spreading melanoma, which is the most common subtype. They perform poorly for nodular melanoma (which is often symmetric, has regular borders, and is uniformly colored) and amelanotic melanoma (which lacks pigment). The EFG criteria (Elevated, Firm, Growing) have been proposed as a complement for nodular melanoma detection.
The ABCDE checklist is a screening tool with imperfect sensitivity and specificity. It cannot replace dermoscopy or histopathologic examination. Small melanomas (under 6mm) are increasingly recognized, which limits the usefulness of the diameter criterion. The Evolution criterion is often considered the most important single factor, as melanomas typically change over weeks to months, but it requires a history of observation. Patients with many atypical moles (dysplastic nevus syndrome) may have multiple moles meeting ABCDE criteria, making individual assessment more challenging.
For related assessments, see DLQI Score, PASI Score and Burns BSA.
Disclaimer: This tool is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with questions about your health.
April 21, 2026 · trust-baseline
Clinical trust metadata enabled for this tool page with structured review/version fields.
Calculate the Dermatology Life Quality Index (DLQI) to measure skin disease impact on quality of life. Score >10 indicates very large effect and is the NICE threshold for biologic therapy eligibility.
OpenDermatologyCalculate the Psoriasis Area and Severity Index (PASI) to assess psoriasis severity across four body regions. Scores range from 0 to 72. Pair with [DLQI Score](/tools/dlqi) for biologic eligibility assessment.
OpenDermatologyEstimate total body surface area (TBSA) affected by burns using the Rule of Nines. Enter affected areas to calculate total burn percentage. Then use TBSA result in [Parkland Formula](/tools/parkland-formula) for fluid resuscitation.
Open